$232.13 +5.46 (%) Actavis PLC - NYSE

Oct. 21, 2014 | 04:00 PM

Partner Headlines

  1. Report: Actavis, Sanofi To Bid On Over-The-Counter Drug Maker

    Benzinga | Oct. 20, 2014 | 20:15PM EST
  2. Benzinga's M&A Chatter for Monday October 20, 2014

    Benzinga | Oct. 20, 2014 | 19:27PM EST
  3. Alexion: Keeping Up The Suspense Ahead Of Q3 Earnings

    IBD | Oct. 20, 2014 | 18:01PM EST
  4. Akorn Finds Institutional Support In Base

    IBD | Oct. 17, 2014 | 18:36PM EST
  5. Will Activis Win Competition For Allergan's Affection?

    Benzinga | Oct. 16, 2014 | 11:10AM EST
  6. Actavis Confirms Generic Quillivant XR® Patent Challenge

    Benzinga | Oct. 16, 2014 | 08:09AM EST
  7. AbbVie Board To Shareholders: Vote No On Shire Buy

    IBD | Oct. 16, 2014 | 00:52AM EST
  8. Stocks Pare Losses; Netflix Plunges After Hours

    IBD | Oct. 15, 2014 | 17:12PM EST
  9. Stocks Slump Again Heading Into Close

    IBD | Oct. 15, 2014 | 15:29PM EST
  10. Drug Analysts Mull End Of 'Double Irish' Loophole

    IBD | Oct. 14, 2014 | 13:10PM EST
  11. IBD 50: Medical, Internet Companies Top Q3 Estimates

    IBD | Oct. 13, 2014 | 19:15PM EST
  12. Patents, Taxes Lift Drug M&A

    IBD | Oct. 10, 2014 | 19:05PM EST
  13. IBD 50: Medical, Internet Companies Top Q3 Profit Estimates

    IBD | Oct. 10, 2014 | 18:45PM EST
  14. Drugmaker M&A Goes On, With Or Without Tax Inversions

    IBD | Oct. 10, 2014 | 17:37PM EST
  15. Indexes Slammed As Oil Prices, Stocks Sink

    IBD | Oct. 9, 2014 | 17:05PM EST
  16. Allergan Steeply Raises Guidance, Taunts Valeant

    IBD | Oct. 9, 2014 | 11:56AM EST
  17. Video: 3 Big Cap Biotechs Bucking Market Correction

    IBD | Oct. 8, 2014 | 17:49PM EST
  18. Stock Futures Aim For A Bounce; Symantec Up On Split Reports

    IBD | Oct. 8, 2014 | 09:01AM EST
  19. #PreMarket Primer: Wednesday, October 8: IMF Cuts Global Growth Prospects, Puts A Damper On Wall Street

    Benzinga | Oct. 8, 2014 | 08:19AM EST
  20. Benzinga's M&A Chatter for Tuesday October 7, 2014

    Benzinga | Oct. 7, 2014 | 20:16PM EST
  21. Salix, Actavis Among Big Cap Pharmas In Merger Mambo

    IBD | Oct. 7, 2014 | 19:33PM EST
  22. Allergan deal buzz intensifies

    IBD | Oct. 7, 2014 | 18:49PM EST
  23. Actavis Finds Rx To Grow On Busy Drugmaker M&A Scene

    IBD | Oct. 7, 2014 | 18:33PM EST
  24. Actavis, Jazz, Novo Lead Top World Stocks List

    IBD | Oct. 7, 2014 | 18:08PM EST
  25. Dow Suffers Largest Daily Decline Since July, S&P 500 At 8-Week Lows On Global Growth Concerns

    Benzinga | Oct. 7, 2014 | 16:52PM EST
  26. Allergan, Inc. Spikes On Renewed Interest From Actavis PLC

    Benzinga | Oct. 7, 2014 | 15:50PM EST
  27. Actavis expands antibiotics

    IBD | Oct. 6, 2014 | 18:45PM EST
  28. Generics Firms Step Up Their Game In Branded Drugs

    IBD | Oct. 6, 2014 | 18:08PM EST
  29. Markets Begin The Week On A Losing Note Ahead Of Earnings Kick Off, Fed Minutes

    Benzinga | Oct. 6, 2014 | 16:45PM EST
  30. EZchip Falls On Lowered Sales Forecast; Durata Therapeutics Shares Jump

    Benzinga | Oct. 6, 2014 | 15:27PM EST
  31. U.S. Stocks Turn Red; CareFusion Shares Surge On Announcement Of Acquisition By Becton, Dickinson

    Benzinga | Oct. 6, 2014 | 14:00PM EST
  32. Markets Open Higher; Hewlett-Packard Plans To Split Into Two Companies

    Benzinga | Oct. 6, 2014 | 10:58AM EST
  33. Actavis Expands Antibiotics Presence With Durata Buy

    IBD | Oct. 6, 2014 | 10:58AM EST
  34. Benzinga's Volume Movers

    Benzinga | Oct. 6, 2014 | 10:25AM EST
  35. Stocks Hitting 52-Week Highs

    Benzinga | Oct. 6, 2014 | 10:15AM EST
  36. Morning Market Movers

    Benzinga | Oct. 6, 2014 | 09:42AM EST
  37. Gilead Among Top IBD 50 Stocks Heading Into Earnings

    IBD | Oct. 4, 2014 | 08:02AM EST
  38. Salix Bails On Tax Inversion

    IBD | Oct. 3, 2014 | 18:47PM EST
  39. Nasdaq, S&P 500 Aim For 50-Day Lines; Alexion Breaks Out

    IBD | Oct. 3, 2014 | 13:32PM EST
  40. Salix Cancels Tax Inversion, Opens Way For Buyers

    IBD | Oct. 3, 2014 | 11:11AM EST
  41. SALIX PHARMACEUTICALS

    IBD | Oct. 2, 2014 | 18:45PM EST
  42. Top Fund Buys: Chipotle, Allergan, Jazz, Gilead

    IBD | Oct. 2, 2014 | 18:25PM EST
  43. Actavis rival results positive

    IBD | Oct. 1, 2014 | 18:43PM EST
  44. Ardelyx Bowel Drug Could Rival Actavis' Linzess

    IBD | Oct. 1, 2014 | 12:10PM EST
  45. Ireland Exporters Look To Thursday's ECB Policy Vote

    IBD | Sep. 30, 2014 | 18:24PM EST
  46. Facebook Among 5 IBD 50 Stocks Holding Near Highs

    IBD | Sep. 27, 2014 | 08:02AM EST
  47. Meet 5 Top Stocks With Rising Earnings Estimates

    IBD | Sep. 26, 2014 | 08:02AM EST
  48. Benzinga's M&A Chatter for Wednesday September 24, 2014

    Benzinga | Sep. 24, 2014 | 21:09PM EST
  49. Pharma Buyout Bids Beat On

    IBD | Sep. 24, 2014 | 18:55PM EST
  50. Facebook, Three Other Leaders In Striking Distance

    IBD | Sep. 24, 2014 | 18:08PM EST
Trading Center